The study included breast cancer survivors that underwent chemotherapy or surgery and radiation alone. All women taking minoxidil saw improved hair growth or stabilized hair loss within 3 to 6 months.

Low-dose oral minoxidil effectively promotes hair regrowth in breast cancer patients with chemotherapy-induced alopecia, without significant cardiovascular risks. A study of 51 patients showed ...

Oral minoxidil is FDA-approved for high blood pressure but is sometimes used off-label for hair loss. They produce similar ...

The rate of pericardial effusion in oral minoxidil adverse event reports were relatively low and were independent of the dose received.

Topical minoxidil works as a hair growth stimulator ... an improvement in hair growth and increased hair count in clinical trials over two years. Deciding between finasteride and minoxidil ...

The researchers also compared the results of this study with results from a separate clinical trial of minoxidil and concluded that 5% ET-02 yields more non-vellus hair growth over the span of 4 ...

The net rate of hair growth produced by ET-02 in the fourth month of treatment was four times greater than the amount produced by minoxidil in a second, separate pre-clinical study (N=103 ...

Rogaine contains the active ingredient minoxidil, which has overwhelmingly been shown to effectively treat hair loss in clinical trials. And the clinicians I spoke to recommended it for women as ...

Nine years later, minoxidil cream was marketed as treatment ... but was originally developed as an antiangina drug. On clinical trials, it was not particularly successful for that indication ...